Gentamicin for RDEB
Condition(s):Recessive Dystrophic Epidermolysis BullosaLast Updated:July 23, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Recessive Dystrophic Epidermolysis BullosaLast Updated:July 23, 2019Completed
Condition(s):Junctional Epidermolysis BullosaLast Updated:April 7, 2020Recruiting
Condition(s):Recessive Dystrophic Epidermolysis BullosaLast Updated:November 3, 2022Recruiting
Condition(s):Postoperative Urinary Tract Infection; Pelvic Organ Prolapse; Stress Urinary IncontinenceLast Updated:November 8, 2022Completed
Condition(s):Junctional Epidermolysis BullosaLast Updated:November 3, 2022Recruiting
Condition(s):Peritoneal Dialysis-related InfectionLast Updated:February 22, 2022Unknown status
Condition(s):Epidermolysis BullosaLast Updated:May 3, 2022Completed
Condition(s):Urinary Tract InfectionsLast Updated:April 9, 2015Unknown status
Condition(s):Urinary Tract Infections; Spinal Cord Injuries; Spinal Cord Diseases; Neurogenic BladderLast Updated:March 6, 2023Active, not recruiting
Condition(s):Surgical Wound InfectionLast Updated:August 16, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.